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transfusion due to the formation of HLA antibodies 
from previous exposure through transfusion or 
5pregnancy, called alloimunization .
Patients number 18 was a manget aplatelet 
transfusion which have been in storage over 3 days. 
This patient was diagnosed with suspected ITP and 
bleeding gums. These patients did not experience 
the event may be due to the effects of medication 
FNHTR pre-transfusion and because there is only 
risk factor platelet stored over 3 days.
Patient number 13 was a man with a 
diagnosis suspect of anemia aplastica and urinary 
tract infections. Patients never been get platelet 
transfusion and get sold less than 3 days. The 
FNHTR did not happen may be due to the effects of 
medication pre-transfusion. 
Another study concluded that the duration 
of platelet storage less than 3 days associated with 
11,12the lower incidence of FNHTR . Incidence of 
FNHTR higher after infusion of platelets stored of 
13about 4 to 5 days . This study has several 
limitations. First, the number of samples of this 
study is less than the minimum sample size 
calculation that will affect the statistical analysis. 
Second, factors suspected to affect FNHTR not 
measured quantitatively.
CONCLUSION
Pre-transfusion medicat ions with 
acetaminophen 650 mg and diphenhydramine 25 
mg reduced the incidence of FNHTR compared to 
placebo in the first platelet recipients in malignancy.
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ABSTRACT
Background.Non alcoholic fatty liver 
disease (NAFLD) is a prevalent condition 
associated with obesity and insulin resistance. 
Leptin is an adipokine which plays role in 
decreasing food intake and controlling energy 
utilization. The role of leptin pathogenesis of 
NAFLD remains unclear. Former studies associated 
with the role of leptin in NAFL were never conducted 
in diabetic patients. 
Aim of study. The aim of the study is to 
analyze the difference of leptin level in non-diabetic 
population between subjects with and without non-
alcoholic fatty liver disease.
Method.This was a non-matching case 
control study in general check-up polyclinic Dr. 
Sardjito Hospital Yogyakarta. The inclusion criteria 
were aged 30-60 years old, no history of alcohol 
consumption > 20 gr/day, no diabetes mellitus. The 
exclusion criteria were viral hepatitis (B and C), 
rapid weight loss, steroid therapy, and pregnancy.  
Diagnosis of NAFL was based on bright liver 
imaging from ultrasonography. 
Result. There were 48 subjects, consisted of 
23 subjects with NAFL and 25 subjects without 
NAFL. Mean of leptin level in NAFL group was 
higher than non NAFL group and this difference was 
statistically significant (20.29 + 15.73ng/ml and 
12.27 + 10.1ng/ml; p=0.040).
Conclusion.The conclusion of this study 
was leptin level significantly higher in non diabetic 
population with NAFL compared with non NAFL.
Keywords: leptin, non diabetic, non alcoholic fatty 
liver 
INTRODUCTION
Today, Non-Alcoholic Fatty Liver Disease 
(NAFLD) is one of clinical condition often found at 
1hepatology area . There is an increasing incidence of 
NAFLD in metabolic syndrome that consists of 
obesity, hyperinsulinaemia, perifer insulin 
resistance, diabetes mellitus, hypertrigliseridaemia 
2and hypertension . NAFLD has a very wide clinical 
spectrum from the lightest to the heaviest, namely 
simple steatosis or non alcoholic fatty liver (NAFL), 
fatty liver with espoused inflammation and damage 
hepatocyte often called as nonalcoholic steato 
hepatitis (NASH), and hepatic cirrhosis, or 
3hepatocellular carcinoma . At this time, NAFLD is 
important in clinical implication as the major cause 
of transaminase enzyme increment in America. 
Besides, NAFLD has a potential capability to be 
4liver cirrhosis and hepatocellular carcinoma . 
In western population, the NAFLD 
prevalence ranged from 15%-20%. NAFLD 
prevalence in adult population at United States, 
Japanese and Italian revolve 15-20%; and 20-30% 
presented in severe phase like NASH. Studies in 
obese population at developed countries found 60% 
simple steatosis, 20-25% NASH and 2-3% cirrhosis. 
NAFLD incident in diabetes mellitus type 2 
populations was as big as 70% and in patient with 
hyperlipidaemia 60%. Based on existing studies, the 
4prevalence of NAFLD in Indonesia is 30.6% .
Leptin is a product of gene ob molecule 
weighing 16kDA that expressed a lot at white 
adipose tissue. Leptin also detectable at center nerve 
system, various organ and perifer such as pancreas, 
5,6liver, artless muscle, and others . Leptin works at 
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hypothalamus level to decrease food intake and 
increase energy use. Leptin level increased along 
with the increasing of fat mass 6. 
Nowadays, the pathogenesis of NAFLD is 
still unclear, but it is estimated to be the combination 
of genetics and environment. The tight existence 
between leptin, adipose network and fat storage in 
human body showed the involvement of leptin in 
etiology and pathogenesis of NAFL. However, the 
role of leptin in NAFLD pathogenesis is still 
7,8unclear .
Recently, there is no consensus about 
NAFLD management. Experts have agreed on that 
the management of NAFLD were focused on the risk 
factor managements, like obesity and diabetes. 
Several medicines, like thiazolidinedione and 
metformin are well known to demote leptin 
production. It is also known that weight loss can 
9restore body sensitivity towards leptin . If the 
involvement of leptin in NAFLD pathogenesis is 
clear, along with several therapies related to leptin 
depreciation, supposed that there will be more 
benefit in managing NAFLD.
The Aim of the Study
The aim of the study was to detect the 
differences of leptin level in non diabetic population 
with NAFL and without NAFL.
Method of the Study
The design of this study was a non matching 
case control study, which compared the mean of 
leptin level in subjects with and without NAFL. This 
study was conducted in General Check up Polyclinic 
at Dr. Sardjito General Hospital Yogyakarta. The 
accessible population of the study was patients who 
visited General Check up (GCU) polyclinic with 
range of age 30-60 years old and willing to join the 
study. The inclusion criteria were age 30-60 year, no 
history of alcohol consumption >20 gram/day, no 
history of diabetes mellitus, and ready to signing 
informed consent. The exclusion criteria were viral 
hepatitis (B and C), rapid weight loss, steroid 
therapy, and pregnancy.
Dependent variable is non alcoholic fatty 
liver (NAFL). Independent variable is leptin level. 
Other variables that evaluated were age, sex, height, 
body weight, body mass index, waist circumference, 
total cholesterol, LDL cholesterol, HDL cholesterol, 
triglyceride, ALT, AST, and GGT.
Subject visited GCU in a state of fasting for 
12 hours. Subjects identity were registered using 
research form and physical examination which 
covered blood pressure measurement, body weight, 
waist circumference, and complete physical 
examination, with anamnesis about medicines such 
lipid lowering, corticosteroid, tamioxifen and 
special diet to lose weight. Then, blood taking were 
done in vena as much as ± 20 ml, for 
examiningleptin, triglyseride, total cholesterol, 
LDL, HDL, AST, ALT, and GGT. Blood sample 
examinations were done at Prodia laboratory 
Yogyakarta. All subjects endured USG abdomen at 
Dr. Sardjito General Yogyakarta, to determine 
whether they had bright liver or not. The evaluation 
result of USG was done by 2 gastroenterohepatology 
experts with value kappa 0.95.
Result and Discussion
This study was done from 1 October 2006 to 
31 January 2007 toward 48 subjects; consist of 20 
malesubjects (41.7%) and 28 female subjects 
(58.3%). All subjects were divided into 2 groups 
based on USG examination, namely group with 
NAFL when there was bright liver (description 
hyperechoic homogenous in liver that compared 
with right kidney in USG) and group without NAFL 
when there was no bright liver in USG.
There were 23 subjects with NAFL, consist 
of 12 male subjects (52.17%) and 11 female subjects 
(47.82%); and 25 subjects without NAFL, that 
consist of 8 male subjects (32%) and 17 female 
subjects (68%). Table 1 showed that there were 
significant differences in mean of body mass index, 
waist circumference, TG, HDL, AST, ALT, GGT, 
and leptin level in group with NAFL and group 
without NAFL. Meanwhile, there were no 
significant differences in mean of age, cholesterol, 
and LDL in both groups.
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In table 1, there were differences on the mean of liver enzymes, such as AST, ALT, and GGT between group 
with NAFL and group without NAFL, which was higher in NAFL group. The mean of AST in group with 
NAFL was 32.78 ± 10.25 IU/l, while in group without NAFL 20.04 ± 5.72 IU/l.Although the mean of AST in 
group with NAFL showed a normal range (<37 IU/l), but statistically the mean of AST in group with NAFL 
was higher than group without NAFL (p=<0.001; CI 7.93-16.78).  In group with NAFL the mean of ALT and 
GGT were higher compared to group without NAFL. The mean of leptin level in group with NAFL was 20.29 ± 15.73 ng/ml while in group without NAFL 12.27 ±10.1 ng/ml. The result showed that statistically there 
were significant differences on the mean of leptin level (p = 0.040; CI -15.66 - -0.39). 
Tabel 1. Variables comparison in group with NAFL and group without NAFL
Variable
 
NAFL
 
(n=23)
 without NAFL
 
(n=25)
 p
 
CI 95%
 
Sex
 
Male
 
Female 
 
12 (52.17%)
 
11 (47.82%)  
 
8 (32%)
 
17 (68%)  
 
0.157*
 
 
0.134 -
 
1.394
Age (year) 44.53± 6.39  45.68 ± 5.00  0.424  -1.99 -  4.65
BMI (kg/m2) 28.47± 3.74  22.53 ± 2.95  <0.001  4.14 -  7.65
Waist Circumference (cm) 91.67 ± 9.88  72.78 ± 5.90  <0.001  -23.58 -  -14.20Cholesterol
 
(mg/dl)
 
214.52 ± 41.55
 
212.44 ± 51.21
 
0.878
 
-29.32 -
 
25.16
LDL (mg/dl)
 
135.00 ± 28.73
 
133.72 ± 46.53
 
0.910
 
-23.99 -
 
25.16
HDL (mg/dl)
 
51.57 ± 10.41
 
59.24 ± 10.96
 
0.017
 
-13.32-
 
-1.58
TG (mg/dl)
 
178.30 ± 93.21
 
102.92 ± 37.14
 
0.001
 
31.72-106.16
ALT (IU/L)
 
32.65 ± 17.16
 
21.84 ± 7.22
 
0.006
 
1.76-15.97
AST (IU/L)
 
32.78 ± 10.25
 
20.04 ± 5.72
 
<0.001
 
7.93 -
 
16.78
GGT (IU/L)
 
34.09 ± 18.08
 
23.40 ± 15.21
 
0.031
 
-20.37 -
 
-1.01
Leptin (ng/ml) 20.29 ± 15.73 12.27 ± 10.16 0.040 -15.66 - -0.39
Data displayed in mean± Standard Deviation, all datas were analyzed using Independent Student t test, * analysis 
2X , CI: Confidence Interval, NAFL: non alcoholic fatty liver, BMI: Body Mass Index, LDL: low density 
lipoprotein, HDL: high density lipoprotein, TG: trigliseride, ALT: alanin aminotransferase, AST: aspartat 
aminotransferase, GGT: gamma glutamyltransferase
Table 2. Variable comparison between group with NAFL and without NAFL in male subjects
Variable NAFL  (n=12)  
Without  NAFL  (n=8)  
p  CI  95%
Age (year)
 
43.17 ± 6.19
 
46.38 +
 
6.209
 
0.384
 
-3.16 - 9.58
BMI (kg/m2)
 
28.82+
 
2.87
 
21.60 +
 
2.14
 
<0.001
 
-9.73 - -4.72
Waist Circumference
 
(cm)
 
94.58 ± 10.40
 
73.63 ± 5.34
 
<0.001
 
-29.38 - -12.54
Cholesterol (mg/dl)
 
220.75 +
 
49.00
 
221.38 ± 67.55
 
0.910
 
-53.98 - 55.23
LDL (mg/dl)
 
136.67 +
 
31.93
 
150.38 +
 
65.48
 
0.970
 
-32.19 - 59.60
HDL (mg/dl)
 
47.5 +
 
7.34
 
54.88 +
 
8.97
 
0.069
 
-0.31 - 15.06
TG (mg/dl)
 
219.5 +
 
110.78
 
91.88 +
 
38.06
 
<0.001
 
-213.74- -41.51
ALT (IU/L)
 
40.58 +
 
19.91
 
26.13 +
 
6.98
 
0.031
 
-27.82 -1.09
AST (IU/L)
 
34.0 +
 
6.42
 
22.63 +
 
6.84
 
0.003
 
-17.69 - -5.05
GGT (IU/L) 43.83 + 19.81 22.0 + 8.0 0.003 -37.44 - -6.23
Leptin (ng/ml) 17.64 ± 18.16 6.27 ± 9.93 0.007 -26.53 - 3.79
Data displayed in mean ± Standard Deviation, all datas were analyzed using Mann Whitney U test, CI: Confidence 
Interval, NAFL: non alcoholic fatty liver, BMI: Body Mass Index, LDL: low density lipoprotein, HDL: high 
density lipoprotein, TG: trigliseride, ALT: alanin aminotransferase, AST: aspartat aminotransferase, GGT: 
gamma glutamyltransferase. 
Leptin Level  In Non Diabetic PopulationVolume 2, Number 2, December 2012
Acta Interna - The Journal of Internal Medicine
26
Table 2 showed that on male subjects, there were significant differences on the mean of TG, ALT, 
AST, GGT, leptin, BMI, and waist circumference between group with NAFL and without  NAFL. The mean 
of leptin level of male subjects in group with NAFL was 17.64 ± 18.16 ng/ml, while in the group without 
NAFL was 6.27 ± 9.93 ng/ml.
Table 3. Variable comparison between group with NAFL and without NAFL on female subjects
Variable NAFL
(n=12)
 Without NAFL
(n=8)
 p CI 95%
Age (year)
 
45.64 ± 5.83
 
45.35 +
 
4.51
 
0.926
 
-4.31 -
 
-3.74
BMI (kg/m2)
 
28.09 +
  
4.63
 
22.97 +
 
3.22
 
0.013
 
-8.16 -
 
-2.08
Waist Circumference (cm)
 
88.50 ± 8.64
 
72.38 ± 6.26
 
<0.001
 
-21.9 -
 
-10.33
Cholesterol (mg/dl) 207.73 + 32.53 208.23 ± 43.35  0.853  -30.94 -  31.96
LDL (mg/dl) 133.18 + 26.22 125.88 + 34.16  0.378  -32.33 -  17.64
HDL (mg/dl) 56.00 + 11.73 61.29 + 11.44  0.430  -4.06 -  14.64
TG (mg/dl) 133.36 + 36.80 108.12 + 36.68  0.091  -54.46 -  3.97
ALT (IU/L) 24.00 + 7.33 19.82 + 6.59  0.134  -9.87 -  1.52
AST (IU/L) 31.45 + 13.49 18.82 + 4.86  0.001  -19.95 -  -  5.32
GGT (IU/L) 23.45 + 6.99 24.06 + 17.83  0.225  -9.37 -  10.57Leptin (ng/ml) 23.19 ± 12.06 15.09 ± 9.23 0.122 -17.09 - 0.89
Data displayed in mean ± Standard Deviation, all datas were analyzed using Mann Whitney U test, CI: Confidence 
Interval, NAFL: non alcoholic fatty liver, BMI: Body Mass Index, LDL: low density lipoprotein, HDL: high density 
lipoprotein, TG: trigliseride, ALT: alanin aminotransferase, AST: aspartat aminotransferase, GGT: gamma 
glutamyltransferase. 
Table 3 showed that on female subjects 
there were significant differences on the mean level 
of AST, BMI, and waist circumference between 
group with and without NAFL. The mean of leptin 
level in female subjects with NAFL was 23.19 ± 
12.06 ng/ml, while in the group without NAFL was 
15.09 ± 9023 ng/ml.However, this difference was 
not statistically significant (p = 0.122).
Results from this study showed that the 
average concentrations of leptin level were higher in 
the group with NAFL compared to group without 
NAFL, and the result was consistent only on male 
subjects. While the difference in leptin levels 
between group with NAFL and group without NAFL 
was not statistically significant in female subjects. 
Results from this study is differ from previous 
research conducted by Huang et al. (2008) and 
Chitturi et al. (2002), which states that both groups 
of male and female leptin levels were higher in 
NAFLD and NASH groups compared with control 
7,10. Several previous studies have also shown an 
increase of leptin level in group with NAFLD 
compared to group without NAFLD, but there is no 
further study analyzed in the differences of leptin 
11, 12, 13levelon each gender . Different result showed in 
the study by Chalasani et al. (2003) and Musso et al. 
(2005), ie. both studies showed that leptin level did 
not significantly different in the NASH group and 
14,15control .
The increase of leptin levels in NAFLD 
probably caused by the condition of the 
hyperleptinemia which is related to pro 
inflammation. Leptin is estimated to contribute at 
each stage of the occurence of NAFLD. Leptin can 
also strengthen the process of inflammation and 
fibrosis in the liver. There is an evidence that 
injections of leptin will lead the increasing of level 
of procollagen-1, TGF â1, and TNFá, which leading 
16to inflammation and more severe liver fibrosis .
This study showed that BMI, waist 
circumference, triglycerides, AST, and ALT in group 
with NAFL were higher than group without NAFL, 
conversely lower HDL level showed in group with 
NAFL. These results are consistent with a study by 
Mendez et al. (2005), which showed that in NAFLD 
group there were a higher BMI, higher total 
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cholesterol, higher triglycerides, higher LDL 
cholesterol, lower HDL cholesterol, while AST and 
11ALT levels are higher than the control group .
In NAFLD, usually there was an increase in 
ALT and AST levels, but the increment did not 
exceed 4 times the normal value. In this study, AST 
and ALT levels in the NAFL group still within the 
range of normal values. The increasing of ALT and 
AST in NAFLD was due to the inflammatory 
processes in the liver as the result of tissue damage 
on the liver or steatohepatitis. The study showed that 
ALT and AST values were normal in group with 
NAFL possibly due to the proccesses involved was 
still in the stage of liver steatosis (first hit of the 
pathogenesis of NAFLD).
Table 4. Correlation between leptin and other variables on male
  BMI  Waist 
circumference  
Total 
Cholesterol  
TG  LDL  HDL  ALT  AST
Leptin  r  0.517  0.536  -0.117  0.536  -0.256  -0.198  0.339  0.494
p  0.020  0.015  0.624  0.015  0.276  0.404  0.144  0.027
Analysis were using Spearman correlation, BMI: Body Mass Index, LDL: low density lipoprotein, HDL: high density lipoprotein, 
TG: trigliseride, ALT: alanin aminotransferase, AST: aspartat aminotransferase. 
Table 5. Correlation between leptin and other variables on female
  BMI  Waist circumference  
Total 
Cholesterol  
TG  LDL  HDL  ALT  AST
Leptin
 
r
 
0.441
 
0.514
 
0.089
 
0.193
 
0.156
 
-0.211
 
0.260
 
0.433
p 0.019 0.005 0.652 0.324 0.429 0.282 0.181 0.021
Table 4 showed that leptin level on male 
subjects correlated with BMI, waist circumference, 
triglycerides, and AST. Table 5 showed that leptin 
level on female subjects correlated with BMI, waist 
circumference and AST.
The results of this study showed that leptin 
had correlation with BMI, waist circumference and 
AST levels on both male and female subjects. The 
correlation between BMI and leptin are consistent 
with the theory that leptin level is increasing along 
9with body mass . Research conducted by Chitturiet 
al. (2002), showed the opposite result, whereas, the 
study showed that leptin level has no correlation 
with BMI on both subjects, male and female. In the 
study by Chitturiet al. (2002) found precisely such a 
significant correlation between leptin level with 
10ALT and C-peptida .
Analysis were using Spearman correlation, BMI: Body Mass Index, LDL: low density lipoprotein, HDL: high density lipoprotein, 
TG: trigliseride, ALT: alanin aminotransferase, AST: aspartat aminotransferase. 
Mendez et al. (2005) in his research found 
that in NAFLD subjects; body weight, body mass 
index, central obesity and insulin resistance were 
11higher than control group . The research on 174 
NAFLD subjects with 42 controls showed that bigger 
waist circumference on NAFLD was indicating 
17central obese . 
Waist circumference portrayed more body 
fat because it was not consisted of lots of bone 
structures (spine only), whereas hip circumference 
was correlated with subcutaneous fat tissue than 
intra-abdominal fat because it is influenced by the hip 
circumference of the gluteal muscle mass and the size 
18of pelvis which varies among subject . The existence 
of a strong relation between leptin level and waist 
circumference was estimated to underlie the relation 
10between visceral fat with resistance insulin .
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